Dr. Michael Ohebshalom, MD

NPI: 1568599447
Total Payments
$4,978
2024 Payments
$267.51
Companies
26
Transactions
123
Medicare Patients
34,584
Medicare Billing
$4.0M

Payment Breakdown by Category

Food & Beverage$2,534 (50.9%)
Gifts$2,249 (45.2%)
Education$194.69 (3.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,534 114 50.9%
Gift $2,249 2 45.2%
Education $194.69 7 3.9%

Top Paying Companies

Company Total Records Latest Year
NxThera, Inc. $1,880 7 $0 (2018)
Tosoh Bioscience, Inc. $558.00 1 $0 (2017)
Sumitomo Pharma America, Inc. $353.34 22 $0 (2024)
Boston Scientific Corporation $344.96 8 $0 (2019)
NeoTract Inc. $312.28 12 $0 (2017)
Astellas Pharma US Inc $245.04 15 $0 (2024)
Endo Pharmaceuticals Inc. $136.16 7 $0 (2018)
PFIZER INC. $135.04 5 $0 (2023)
Janssen Biotech, Inc. $126.20 7 $0 (2023)
Abbott Laboratories $125.00 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $267.51 16 Sumitomo Pharma America, Inc. ($217.06)
2023 $526.11 17 Sumitomo Pharma America, Inc. ($136.28)
2022 $110.10 6 Astellas Pharma US Inc ($55.31)
2020 $42.68 2 Allergan, Inc. ($42.68)
2019 $95.82 4 Boston Scientific Corporation ($95.82)
2018 $692.47 28 BOSTON SCIENTIFIC CORPORATION ($249.14)
2017 $3,243 50 NxThera, Inc. ($1,867)

All Payment Transactions

123 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
11/13/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $18.46 General
Category: UROLOGY
10/09/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $16.89 General
Category: UROLOGY
10/09/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $3.34 General
Category: UROLOGY
10/09/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $2.71 General
Category: UROLOGY
10/02/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $25.90 General
Category: HORMONE THERAPY
09/11/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $28.45 General
Category: UROLOGY
08/21/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $23.19 General
Category: UROLOGY
08/21/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $2.21 General
Category: UROLOGY
05/14/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $26.34 General
Category: HORMONE THERAPY
04/17/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $23.52 General
Category: UROLOGY
04/17/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $1.50 General
Category: UROLOGY
04/17/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $0.74 General
Category: UROLOGY
04/03/2024 Astellas Pharma US Inc Myrbetriq (Drug) Food and Beverage In-kind items and services $24.61 General
Category: Urology
03/13/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $23.89 General
Category: UROLOGY
03/11/2024 Ferring Pharmaceuticals Inc. ADSTILADRIN (Biological) Food and Beverage In-kind items and services $25.84 General
Category: ONCOLOGY
01/31/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $19.92 General
Category: UROLOGY
11/13/2023 ABBVIE INC. LUPRON DEPOT (Drug) Food and Beverage In-kind items and services $13.31 General
Category: ENDOCRINOLOGY
11/07/2023 PFIZER INC. XTANDI (Drug), ORGOVYX, COMIRNATY Food and Beverage In-kind items and services $25.05 General
Category: ONCOLOGY
10/24/2023 Verity Pharmaceuticals Inc. Trelstar (Drug) Food and Beverage Cash or cash equivalent $17.24 General
Category: Prostate cancer
10/18/2023 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $20.90 General
Category: Urology
09/08/2023 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $15.37 General
Category: HORMONE THERAPY
08/23/2023 Progenics Pharmaceuticals, Inc. PYLARIFY (Drug) Food and Beverage In-kind items and services $125.00 General
Category: RADIOPHARMACEUTICAL
07/17/2023 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $13.44 General
Category: HORMONE THERAPY
06/28/2023 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $125.00 General
Category: DIABETES CARE
06/19/2023 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $18.34 General
Category: HORMONE THERAPY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 26 8,854 15,481 $1.8M $1.0M
2022 28 8,464 15,603 $1.8M $1.1M
2021 26 9,164 16,843 $1.7M $1.1M
2020 31 8,102 17,807 $1.4M $873,079
Total Patients
34,584
Total Services
65,734
Medicare Billing
$4.0M
Procedure Codes
111

All Medicare Procedures & Services

111 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
51728 Complex measurement of pressure of urine flow in bladder with voiding pressure studies Office 2023 538 564 $256,334 $197,123 76.9%
55899 Other procedure on male genital system Office 2023 653 729 $473,850 $195,506 41.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 760 1,499 $161,128 $116,241 72.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 514 905 $136,719 $94,863 69.4%
76872 Ultrasound scan of pelvic region through rectum Office 2023 653 679 $167,585 $88,152 52.6%
76857 Limited ultrasound scan of pelvis Office 2023 942 1,476 $90,434 $68,003 75.2%
J3490 Unclassified drugs Office 2023 51 810 $202,500 $58,158 28.7%
55874 Injection of biodegradable material next to prostate Office 2023 14 14 $49,985 $39,924 79.9%
51784 Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings Office 2023 792 1,297 $107,284 $37,844 35.3%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2023 111 142 $42,193 $32,097 76.1%
51741 Electronic assessment of bladder emptying Office 2023 801 1,744 $33,766 $13,700 40.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 119 120 $16,342 $11,364 69.5%
11980 Placement of hormone pellet under skin Office 2023 53 139 $16,815 $10,022 59.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 71 71 $14,098 $9,494 67.3%
81003 Automated urinalysis test Office 2023 1,026 2,444 $6,009 $5,377 89.5%
51798 Ultrasound measurement of bladder capacity after voiding Office 2023 382 530 $7,773 $5,360 69.0%
87081 Screening test for pathogenic organisms Office 2023 564 786 $7,305 $5,109 69.9%
36415 Insertion of needle into vein for collection of blood sample Office 2023 674 1,287 $8,937 $4,810 53.8%
55700 Biopsy of prostate gland Office 2023 17 17 $5,008 $3,957 79.0%
51702 Simple insertion of temporary bladder tube Office 2023 18 51 $4,596 $2,534 55.1%
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle Office 2023 21 45 $1,963 $1,355 69.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 27 27 $1,823 $1,299 71.3%
51701 Insertion of temporary bladder tube Office 2023 14 18 $985.18 $788.22 80.0%
76775 Limited ultrasound scan behind abdominal cavity Office 2023 11 11 $786.07 $630.70 80.2%
84153 Psa (prostate specific antigen) measurement, total Office 2023 12 12 $252.29 $216.24 85.7%

About Dr. Michael Ohebshalom, MD

Dr. Michael Ohebshalom, MD is a Specialist healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1568599447.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ohebshalom, MD has received a total of $4,978 in payments from pharmaceutical and medical device companies, with $267.51 received in 2024. These payments were reported across 123 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,534).

As a Medicare-enrolled provider, Ohebshalom has provided services to 34,584 Medicare beneficiaries, totaling 65,734 services with total Medicare billing of $4.0M. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Urology
  • Location Manhasset, NY
  • Active Since 02/27/2007
  • Last Updated 12/13/2022
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1568599447

Products in Payments

  • Rezum (Device) $1,880
  • PA, ST AIA-PACK (Medical Supply) $558.00
  • Urolift - UL400 (Device) $312.28
  • GEMTESA (Drug) $262.64
  • GENERAL BPH (Device) $249.14
  • Myrbetriq (Drug) $232.92
  • XTANDI (Drug) $192.87
  • ORGOVYX (Drug) $145.49
  • FREESTYLE LIBRE 3 (Device) $125.00
  • PYLARIFY (Drug) $125.00
  • GENERAL BPH (Device) $95.82
  • SPEEDICATH (Device) $91.63
  • XIAFLEX (Biological) $79.71
  • FIRMAGON (Drug) $70.36
  • Androgel (Drug) $66.69
  • ZYTIGA (Drug) $64.24
  • BOTOX (Biological) $42.68
  • Erleada (Drug) $36.23
  • BOTOX THERAPEUTIC (Biological) $32.92
  • AVEED (Biological) $32.84

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Manhasset